Introduction to Plco Trial

Sentence Examples

Discover more insights into Plco Trial

Keywords frequently search together with Plco Trial

Narrow sentence examples with built-in keyword filters

More Plco Trial sentence examples

10.1002/cncr.32605

The PLCO trial showed no mortality benefit for PSA screening at 10 years, whereas the ERSPC trial demonstrated a 20% reduction in prostate cancer mortality at 9 years, though PSA screening was associated with a very high rate of overdiagnosis.

Full Text

More Plco Trial sentence examples

10.1158/1538-7445.AM2019-604

Methods: We used data from a nested case-control study within the screening arm of the PLCO trial (353 endometrial cancer cases, 353 controls, age 55-74 years at enrollment).

Full Text

More Plco Trial sentence examples

10.1016/j.lungcan.2019.11.024

MISCAN-Lung was calibrated to the NLST and PLCO trials and incorporates birth-cohort-specific smoking trends and life expectancies.

Full Text

More Plco Trial sentence examples

10.1016/j.clgc.2018.12.010

Conclusion: Prostatectomy seems to predict better overall and prostate cancer‐specific survival compared with radiation therapy among patients with clinically localized prostate cancer diagnosed within the PLCO trial.

Full Text

More Plco Trial sentence examples

10.1016/S2468-1253(18)30358-3

METHODS Participants in the PLCO trial were recruited from the general population in the catchment areas of ten screening centres across the USA, without previous diagnosis of a prostate, lung, colorectal, or ovarian cancer or current cancer treatment.

Full Text

More Plco Trial sentence examples

10.2217/fon-2019-0292

Methods: PLCO trial participants without a history of thyroid cancer before study enrollment who have complete information about prediagnostic BMI were included.

Full Text

More Plco Trial sentence examples

10.1007/s00120-019-0900-y

ResultsIn contrast to the CAP and PLCO trial, the ERSPC study reports a reduced relative and absolute mortality risk.

Full Text

More Plco Trial sentence examples

10.1097/01.JU.0000556133.28739.2a

METHODS: We used the PLCO trial with 13-yr follow-up to identify 27,656 men in the screening arm with baseline PSA and outcome data.

Full Text

Learn more from Plco Trial

Keywords related to Plco

Plco Cohort Plco Cancer Explore More

Keywords related to Trial

Program Trial Iib Trial Iia Trial Avocado Trial Coapt Trial Platform Trial Remap Covid Trial Patient Centered Trial Discontinuation Trial Radiotherapy Trial Multisite Trial Evaluation Trial Table Trial Hut Trial Single Arm Trial Response Trial Companion Trial 3 Trial Cher Trial Advance Trial Woman Trial Making Trial Crimes Trial Definitive Trial Start Trial Cll4 Trial Reduce Trial Human Trial Aneurysm Trial Discovery Trial Education Trial Voice Trial Mindact Trial Treatment Trial Synergy Trial Hope 3 Trial Recognition Trial Solo Trial Target Trial Popart Trial Polo Trial Registry Trial Phase Trial Superiority Trial Recovery Trial Maintenance Trial Stamina Trial Bell Trial Syntax Trial Evolve Trial Explore More

Plco Trial

Encyclopedia

Mar 25, 2023

What is/are Plco Trial?

Plco Trial - The PLCO trial showed no mortality benefit for PSA screening at 10 years, whereas the ERSPC trial demonstrated a 20% reduction in prostate cancer mortality at 9 years, though PSA screening was associated with a very high rate of overdiagnosis. ^[1] Methods: We used data from a nested case-control study within the screening arm of the PLCO trial (353 endometrial cancer cases, 353 controls, age 55-74 years at enrollment). ^[2] MISCAN-Lung was calibrated to the NLST and PLCO trials and incorporates birth-cohort-specific smoking trends and life expectancies. ^[3] Conclusion: Prostatectomy seems to predict better overall and prostate cancer‐specific survival compared with radiation therapy among patients with clinically localized prostate cancer diagnosed within the PLCO trial. ^[4] METHODS Participants in the PLCO trial were recruited from the general population in the catchment areas of ten screening centres across the USA, without previous diagnosis of a prostate, lung, colorectal, or ovarian cancer or current cancer treatment. ^[5] Methods: PLCO trial participants without a history of thyroid cancer before study enrollment who have complete information about prediagnostic BMI were included. ^[6] ResultsIn contrast to the CAP and PLCO trial, the ERSPC study reports a reduced relative and absolute mortality risk. ^[7] METHODS: We used the PLCO trial with 13-yr follow-up to identify 27,656 men in the screening arm with baseline PSA and outcome data. ^[8]